LGG-02. Cardiac toxicity in patients receiving single-agent MEK inhibition

BACKGROUND: MEK inhibitor therapy is increasingly being utilized for the treatment of pediatric tumors, including low-grade glioma, plexiform neurofibroma and Langerhans cell histiocytosis. These drugs are well-tolerated but do have risk of toxicity, including cardiac toxicity. The purpose of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantor, Evan, Shatara, Margaret, Meyers, Ashley, Ogle, Andrea, McHugh, Michele, Reiners, Stephanie, Cluster, Andrew, Abdelbaki, Mohamed S, Navalkele, Pournima, Brossier, Nicole M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Low Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165047/
http://dx.doi.org/10.1093/neuonc/noac079.318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165047/
http://dx.doi.org/10.1093/neuonc/noac079.318

Ejemplares similares